paperKB
coga / coga-kb
Help
Sign in

Chunk #2 — 1. INTRODUCTION

Source
Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
Embedded
yes

Text

et al., 2011). Further studies have demonstrated change in the receptor function in response to nicotine agonists given this amino acid change in the a5 nicotinic receptor subunit (Bierut et al., 2008a; Brown et al., 2007). Growing evidence indicates that rs16969968 in CHRNA5 is a predictor for smoking cessation in some circumstances and predicts a delay in successful smoking cessation (Baker et al., 2009; Bergen et al., 2013; Chen et al., 2012, 2015; Freathy et al., 2009; Munafo et al., 2011; Sarginson et al., 2011; Zhu et al., 2014).